Valneva receives Brazilian marketing authorization for single-dose vaccine Ixchiq for prevention of disease caused by ...
Valneva SE, a specialty vaccine company, announced that the Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization to its single-dose vaccine Ixchiq for the prevention of disease caused by the chikungunya virus in individuals 18 …